November 16, 2016 - By kentuckypostne · 0 Comments
Transcat Inc (NASDAQ:TRNS) institutional sentiment increased to 2.33 in Q2 2016. Its up 1.70, from 0.63 in 2016Q1. The ratio is better, as 7 investment professionals increased or started new stock positions, while 3 cut down and sold their stakes in Transcat Inc. The investment professionals in our partner’s database now possess: 2.60 million shares, up from 2.44 million shares in 2016Q1. Also, the number of investment professionals holding Transcat Inc in their top 10 stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 1 Reduced: 2 Increased: 6 New Position: 1.
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The company has a market cap of $72.21 million. The Firm conducts its business through two divisions: service and distribution (Distribution). It has a 16.8 P/E ratio. Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
It is down 10.28% since April 14, 2016 and is downtrending. It has underperformed by 14.97% the S&P500.
According to Zacks Investment Research, “Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace.”
Minerva Advisors Llc holds 2.81% of its portfolio in Transcat, Inc. for 413,754 shares. Grandeur Peak Global Advisors Llc owns 180,543 shares or 0.37% of their US portfolio. Moreover, Heartland Advisors Inc has 0.34% invested in the company for 600,000 shares. The Minnesota-based Punch & Associates Investment Management Inc. has invested 0.18% in the stock. Ativo Capital Management Llc, a Illinois-based fund reported 68,285 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 2 insider purchases, and 8 sales for $263,198 net activity.
Transcat, Inc., incorporated on March 19, 1964, is a well-known provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Firm conducts its business through two divisions: service (Service) and distribution (Distribution). The Firm is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses. The Firm also focuses on other industries, which include industrial manufacturing; energy and utility, including gas and oil; chemical manufacturing, and Federal Aviation Administration (FAA)-regulated business, including aerospace and defense and other industries. The Company’s subsidiaries include Transcat Canada Inc., United Scale & Engineering Corporation, WTT Real Estate Acquisition, LLC and Anacor Acquisition, LLC.
More notable recent Transcat, Inc. (NASDAQ:TRNS) news were published by: Globenewswire.com which released: “Transcat, Inc. to Present at 2016 Midwest IDEAS Investor Conference” on August 17, 2016, also Globenewswire.com with their article: “Transcat, Inc. to Present at Midwest Investment Conference 2016” published on June 13, 2016, Streetinsider.com published: “Transcat, Inc. (TRNS) Acquires Excalibur Engineering in $7.35M Deal” on April 01, 2016. More interesting news about Transcat, Inc. (NASDAQ:TRNS) were released by: Globenewswire.com and their article: “Transcat, Inc. to Present at 2016 Southwest IDEAS Investor Conference” published on October 25, 2016 as well as Democratandchronicle.com‘s news article titled: “Transcat acquires Excalibur Engineering” with publication date: April 11, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.